A preliminary study of serotonergic antidepressants in treatment of dysthymia.
There is increasing evidence that antidepressants may alleviate symptoms of dysthymia, but few prior studies on selective serotonergic agents. Twenty patients meeting criteria for dysthymia, but not meeting criteria for major depression, received open label trials of a serotonergic antidepressant, either fluoxetine or trazodone. Seventeen (85%) completed three-month medication trials, and of these, twelve (70.6% of completers) responded to treatment. Seven (41.2% of completers) were still in remission on follow-up at five months. Both fluoxetine and trazodone were well tolerated in dysthymics, and showed similar short-term effectiveness in treating dysthymic symptoms.
Rosenthal
J
J
Beth Israel Medical Center, New York, N.Y.
Hemlock
C
C
Hellerstein
D J
DJ
Yanowitch
P
P
Kasch
K
K
Schupak
C
C
Samstag
L
L
Winston
A
A
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012701:Serotonin / Q000502:physiology*; D014196:Trazodone / Q000627:therapeutic use*
D000928:Antidepressive Agents; D005473:Fluoxetine; D012701:Serotonin; D014196:Trazodone